[1] |
ZHANG Pei-ze, ZHENG Jun-feng, CAO Wei-peng, WANG Yu-xiang, CHEN Tao, FU Liang, DENG Guo-fang.
Study of the serum concentration at two time points after taking rifampicin
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 493-497.
|
[2] |
LIN Jian, LIN Shu-fang, DAI Zhi-song, ZHAO Yong, WEI Shu-zhen, ZHOU Yin-fa.
Study on the distribution and epidemiological characteristics of non-tuberculous mycobacterium strains in Fujian Province
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 518-522.
|
[3] |
Ming-wu LI,Ming-hong LAI,Meng MA,Rong WAN,Yuan XU,Chao-mei DU.
Analysis on the monitoring results of plasma-drug concentration of rifampicin in different dosage forms
[J]. Chinese Journal of Antituberculosis, 2019, 41(6): 645-649.
|
[4] |
Jun ZHOU,Xiao-hui LYU,Xiu-qi ZHENG,Chao-gang XIONG,Yuan ZHAO,Li-yun DANG.
Comparative analysis of the adjustment success ratio of plasma drug concentration of three anti-tubercular drugs
[J]. Chinese Journal of Antituberculosis, 2018, 40(9): 969-972.
|
[5] |
Shao-chen GUO,Hui ZHU,Chao GUO,Bin WANG,Zhong-quan LIU,Jian XU,Lei FU,Xiao-you CHEN,Yu LU.
Analysis of plasma concentrations of first-line anti-tuberculosis drugs in 909 tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2018, 40(7): 744-749.
|
[6] |
ZHU Hui,LIU Zhong-quan,XIE Li,GUO Shao-chen,WANG Bin,FU Lei,LU Yu.
Determination of bedaquiline plasma concentration by high performance liquid chromatography-mass spectrometry/mass spectrometry
[J]. Chinese Journal of Antituberculosis, 2018, 40(12): 1319-1324.
|
[7] |
LIN Shu-fang, CHEN Qiu-yang, ZHENG Jin-feng, WEI Shu-zhen, DAI Zhi-song, LIN Yong-ming.
The evaluation of implementation effect of tuberculosis control program in Fujian province during 2001—2010
[J]. Chinese Journal of Antituberculosis, 2013, 35(1): 65-69.
|
[8] |
YANG Hua-lin, BAO Chang-lin, BAI Li-qiong, LI Yan-hong, GONG De-hua, TANG Yi, WAN Yan-ping, XIAO Tao, FAN Jiang-jing, CHEN You-fang.
Comparison between the effects of interventions of telephone supervision and traditional supervision to the pulmonary TB patients in Hunan rural areas
[J]. Chinese Journal of Antituberculosis, 2011, 33(10): 646-650.
|
[9] |
Chen Zifang,Wei Haidong,Lao Haili,Hu Lizhen,Wang Songtao,Zhou Lei.
Analysis on nosocomial infectious pathogens and drug susceptible test in the inpatients with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2010, 32(1): 40-44.
|
[10] |
Lin Shufang, Chen Qiuyang, Du Yongcheng, Lin Yongming, Dai Zhisong.
Discussions on strengthening the cooperation between the general hospitals and TB dispensaries to improve the case-detection of pulmonary tuberculosis in Fujian province
[J]. Chinese Journal of Antituberculosis, 2009, 31(1): 26-28.
|
[11] |
Lin Yongming,Chen Qiuyang,Liu Xiaoyun,et al..
Analysis of DOTS strategy implementation in rural and mountainous area in Fujian province
[J]. Chinese Journal of Antituberculosis, 2006, 28(6): 348-350.
|
[12] |
Zheng Jinfeng,Ou Jianming,Liu Tanye,et al..
The analysis of the register,reporting and treatment outcome of pulmonary tuberculosis in Fujian province in eight years
[J]. Chinese Journal of Antituberculosis, 2006, 28(5): 281-284.
|
[13] |
Li Hong,Tangshenjie..
A clinical trial of Mycobaeterium Vaccae vaccine combining chemotherapy in treating new pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2006, 28(4): 241-243.
|
[14] |
Chen Qiuyang,Zheng Jinfeng,Wu Nengjian..
Analysis on the correlated factors of delay in tuberculosis diagnosis and treatment in Fujian province
[J]. Chinese Journal of Antituberculosis, 2005, 27(6): 374-379.
|
[15] |
Huang Xuerui,Gao Weiwei,Bu Jianling,et al..
Analysis of therapeutic effect on the individualized regimens for 69 patients with multi-drug resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2004, 26(5): 257-260.
|